Bicycle Therapeutics plc — Income Charts
12 quarters of history · ending 2026-03-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-91.1% -$9M
$887K
R&D↓-17.2% -$10M
$49M
D&A↓-30.9% -$505K
$1M
Operating Income↑+6.7% +$5M
$-65M
EBITDA↑+6.1% +$4M
$-64M
Interest Expense↓-5.9% -$3K
$48K
Other Income/Expense↓-42.0% -$4M
$5M
Pretax Income↑+1.9% +$1M
$-61M
Tax Provision↑+115.8% +$1M
$172K
Net Income↓-0.1% -$71K
$-61M
Operating Margin↓-6678.8pts
-7382.4%
Net Margin↓-6248.4pts
-6857.4%
Effective Tax Rate↓-2.0pts
-0.3%
ETR (Continuing Operations)↓-2.8pts
-0.1%
ETR Federal Statutory↑+0.0pts
25.0%
ETR Foreign Differential (pp)↓-5.3pts
-6.3%
Operating Lease Cost↑+8.1% +$101K
$1M
Revenue YoY Variation↓-42.2pts
-91.1%
Income YoY Variation↑+128.1pts
6.7%
Revenue QoQ Variation↓-267.2pts
-98.2%
Income QoQ Variation↑+61.2pts
24.3%